NASH
(PDF, 52KB) |
Multi-Center clinical trials and studies in patients with NAFLD, NASH or cryptogenic cirrhosis
|
CRADAs |
Capability Statements due on or before May 30, 2008
|
Drug Induced Liver Injury Network (DILIN)
(PDF, 35KB) |
Collaborations/Public-Private Partnerships to Extend Efforts to Understand and Prevent Drug Induced Liver Injury
|
Collaboration/Public-Private Partnership
|
Written responses requested – period open |
Acute Liver Failure Study Group (ALFSG)
(PDF, 34KB) |
Multi-center clinical trials of novel therapies and diagnostics for patients with acute liver failure
|
Clinical Trials and CRADAs
|
Closed September 30, 2007 (contact Patricia Lake for additional information)
|
TrialNet Metabolic Control Study
* Amendment
(PDF, 36KB) |
Type 1 Diabetes TrialNet Multi-Center Clinical Trial of the Effects of Metabolic Control on Progression of Type 1 Diabetes |
Clinical Trial |
Closed July 13, 2007 (contact Patricia Lake for additional information) |
Hepatitis B Clinical Research Network (Hepatitis B Network)
(PDF, 34KB) |
Multi-center clinical trials of novel therapies and diagnostics for patients with
chronic hepatitis B |
Clinical Trials and CRADA |
Closed 1 February 2007 (contact Rochelle Blaustein
for additional information) |
The Gastroparesis Clinical Research Consortium (GpCRC)
(PDF, 25KB) |
Multi-center clinical trials of novel therapies for patients with well characterized gastroparesis |
Clinical Trials and CRADA |
Closed 15 February 2007 (contact Rochelle Blaustein for
additional information) |
HALT-C (Hepatitis C Antiviral Long-term Treatment against Cirrhosis)
(PDF, 18KB) |
Multi-Center Clinical Trials of Novel Antiviral Therapies for Patients with Chronic Hepatitis C Who Have Not Previously Responded to Standard Therapy |
Clinical Trial |
Closed 22 February 2006 (contact Rochelle Blaustein for additional information) |
2006 NIDDK-Sponsored Symposium
(PDF, 18KB) |
FRONTIERS IN PAINFUL BLADDER SYNDROME AND INSTITIAL CYSTITIS |
Symposium Co-Sponsorship(for agreement, see:
(PDF, 23kb))(for Co-Sponsorship guidance document, see:
(PDF, 5kb))
|
Closed 31 January 2006 (contact Rochelle Blaustein for additional information) |
NIDDK Intramural Research Program (Islet and Autoimmunity Branch)
(PDF, 20KB) |
Development of an Automated System for Improved Glucose Monitoring and Reporting |
Software Development Collaboration |
Closed 31 January 2006 (contact Rochelle Blaustein for additional information) |
NASH
(PDF, 2KB) |
NAFLD, NASH & cryptogenic cirrhosis clinical trials |
Clinical Trial |
Closed 31 January 2006 (contact Rochelle Blaustein for additional information) |
NIDDK Intramural Research Program
(Islet and Autoimmunity Branch)
(PDF, 28KB) |
Prospective, placebo-controlled clinical trial of Peroxisome Proliferator-Activated Receptor Agonist (PPAR) versus placebo to prevent further beta cell loss in young patients with recently-diagnosed, autoimmune-mediated type 1 diabetes |
Clinical Trial |
Written Capability Statements due by 31 January 2006. |
Urinary Incontinence Treatment Network (UITN): Stress Urinary Incontinence (UITN/SUI)
(PDF, 34KB) |
Utilization of Mid-Urethral Slings, Retropublic and Transobdurator Sling placement Devices in a NIH Sponsored Multi-Center Clinical Trial in Women with Stress Urinary Incontinence |
Clinical Trial |
Closed 6 September 2005 (contact Rochelle Blaustein for additional information |
Silymarin Product Development Program (Silymarin PDP)
(PDF,
206KB) |
Silymarin Product Development Program for use in NIH-Sponsored Clinical Trial for Liver Disease |
Clinical Trial |
Closed 23 May 2005 (contact Rochelle Blaustein for additional information) |
Frequent Hemodialysis Network (HFN)
(PDF,
240KB) |
Utilization of Hemodialysis Devices in an NIH-Sponsored Multi-Center Clinical Trial of Frequent Dialysis for Patients with End-Stage Renal Disease (ESRD) |
Clinical Trial |
Closed 12 October 2004 (contact Rochelle Blaustein for additional information) |
Complementary and Alternative Medicine For Urological Symptoms (CAMUS): A Multicenter Trial of Phytotherapy for Benign Prostate Hyperplasia
(PDF,
59KB) |
Utilization of an Alpha-Adrenergic Blocking Drug in a NIH Sponsored Multi-Center Clinical Trial in Men with Lower Urinary Tract Symptoms Attributable to Benign Prostatic Hyperplasia |
Clinical Trial |
Closed 19 August 2004 (contact Rochelle Blaustein for additional information) |
Interstitial Cystitis Clinical Research Network (ICCRN)
(PDF,
16KB) |
Utilization of a urinary alkalinizing agent in a NIH sponsored multi-center clinical trial in patients with the painful bladder syndrome |
Clinical Trial |
Closed 2 June 2004 (contact Rochelle Blaustein for additional information) |
Chronic Prostatitis Collaborative Research Network (CPCRN)
(PDF,
16KB)
| Utilization of an alpha-adrenergic blocking drug in a NIH sponsored multi-center clinical trial in men with chronic prostatitis/chronic pelvic pain syndrome | Clinical Trial | Closed 2 June 2004 (contact Rochelle Blaustein for additional information) |
Focal Segmented Glomerulosclerosis
(PDF,
283KB) |
A prospective, multicenter, randomized, open label
clinical trial to compare the effectiveness of a
treatment regimen including cyclosporine A and ACEI
therapy to a regimen including mycophenolate mofetil
(MMF), oral pulse steroids, and ACEI therapy in
inducing remission of proteinuria in patients with
steroid resistant FSGS |
Clinical Trial |
Closed 15 October 2003 (contact Rochelle Blaustein for additional information) |
Focal Segmented Glomerulosclerosis
(PDF,
241KB) |
A prospective, multicenter, randomized, open label
clinical trial to compare the effectiveness of a
treatment regimen including cyclosporine A and ACEI
therapy to a regimen including mycophenolate mofetil (MMF),
oral dexamethasone, and ACEI therapy in inducing remission
of proteinuria in patients with steroid resistant FSGS |
Clinical Trial |
Closed 15 October 2003 (contact Rochelle Blaustein for additional information) |
Urinary Incontinence
(PDF,
258KB) |
Utilization of an antimuscarinic anticholinergic
drug in a multi-center clinical trial of combined
behavioral therapy and drug therapy in women with urge
urinary incontinence |
Clinical Trial |
Closed 15 August 2003 (contact Rochelle
Blaustein for additional information) |
Living Donor Liver Transplantation
(PDF,
287KB) |
Scientific investigations of living donor liver
transplantation using clinical information and tissue
and blood samples from adult liver transplant recipients
|
Clinical Trial |
closed 21 July 2003 (contact Rochelle
Blaustein for additional information) |
BARC
(PDF,
287KB) |
Prospective, randomized,
placebo-controlled multi-center clinical trial of
corticosteroids versus placebo in patients undergoing
hepatoportoenterostomy for biliary atresia |
Clinical Trial and CRADAs |
closed 9 July 2003 (contact Rochelle
Blaustein for additional information) |
PKD
(PDF,
191KB) |
Multi-center randomized clinical trials studying the
impact of combined angiotensin converting enzyme (ACE)
inhibitor and angiotensin receptor blocker (ARB) therapy
on kidney disease progression in hypertensive patients
with Polycystic Kidney Disease (PKD) |
Clinical Trial |
closed 9 June 2003 (contact Rochelle
Blaustein for additional information) |
Type 2 Diabetes
(PDF,
234KB) |
Treatment of type 2 diabetes in pediatric
population: children and adolescents |
Clinical Trial |
closed 21 April 2003 (contact Rochelle
Blaustein for additional information) |
NASH
(PDF,
284KB) |
Prospective, randomized, controlled, multi-center
clinical trial of vitamin E versus an
insulin-sensitizing agent versus placebo in patients
with well characterized nonalcoholic steatohepatits
(NASH) |
Clinical Trial and CRADAs |
closed 11 April 2003 (contact Rochelle
Blaustein for additional information) |
|
